{"doi":"10.1186/2051-1426-2-s3-o7","title":"Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer","abstract":null,"journal":"Journal for ImmunoTherapy of Cancer","year":2014,"id":590718,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":366354,"name":"Rakesh Verma","orcid":"0000-0002-0832-6676","position":1,"is_corresponding":false},{"id":819153,"name":"Mario Sznol","orcid":"0000-0003-4137-9662","position":2,"is_corresponding":false},{"id":1511328,"name":"Chandra Sekhar Boddupalli","orcid":null,"position":3,"is_corresponding":false},{"id":1573,"name":"Scott Gettinger","orcid":"0000-0003-0886-6880","position":4,"is_corresponding":false},{"id":1511329,"name":"Harriet Kluger","orcid":null,"position":5,"is_corresponding":false},{"id":1511330,"name":"Madhav Dhodapkar","orcid":null,"position":6,"is_corresponding":false},{"id":900991,"name":"Rituparna Das","orcid":"0000-0002-5166-0311","position":7,"is_corresponding":false},{"id":110549,"name":"Kavita Dhodapkar","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer","abstract":"Meeting abstracts Therapies targeting T cell immune checkpoints such as CTLA4 and PD1/PDL1 axis have shown considerable promise in the therapy of human cancer. Combination therapy with dual immune checkpoint blockade (ICB) was recently shown to be highly active in melanoma. While signaling via both","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"20725694","pmcid":"PMC4288370","openalex_id":"https://openalex.org/W2085972006","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.11071921,"influential_citations":0,"citation_trend":[],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://jitc.bmj.com/content/jitc/2/Suppl_3/O7.full.pdf","host_type":"journal"},{"url":"https://jitc.bmj.com/content/jitc/2/Suppl_3/O7.full.pdf","host_type":"publisher"},{"url":"http://link.springer.com/content/pdf/10.1186/2051-1426-2-S3-O7.pdf","host_type":"publisher"},{"url":"https://doi.org/10.1186/2051-1426-2-s3-o7","host_type":"journal"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4288370","host_type":"repository"}],"fields_of_study":["Cancer Immunotherapy and Biomarkers","Advanced Breast Cancer Therapies","Immune cells in cancer"],"mesh_terms":[],"keywords":["Blockade","Immune checkpoint","CTLA-4","Medicine","Ipilimumab","Cancer research","Melanoma","Cancer","PD-L1","Immune system","In vivo","T cell","Oncology","Immunotherapy","Immunology","Internal medicine","Receptor","Biology"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-25T10:13:11.648282Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}